Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ALS
MedTech
Synchron's brain-computer interface hits one-year safety mark
One year after placement of Synchron's Stentrode implant, no study participants have experienced any adverse events that led to disability or death.
Andrea Park
Mar 31, 2022 10:40am
Orphazyme on last legs amid restructuring, more layoffs
Mar 10, 2022 6:24pm
Maze snares $190M as its top asset aims for clinic
Jan 10, 2022 7:30am
After FDA U-turn, Amylyx heads for IPO to support ALS drug
Dec 17, 2021 10:45am
ALS organizations call on Senate to pass $500M neuro R&D bill
Dec 9, 2021 4:00pm
Denali makes ALS play, hustling Sanofi-allied drug into phase 2
Oct 7, 2021 7:35am